Sankala Group »

Eledon Pharmaceuticals shares owned by Sankala Group

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Sankala Group from 13F filings

Historical chart of Sankala Group investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Sankala Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Sankala Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.1k 1.4k 3.60

More positions owned by Sankala Group

Ishares Treasury Floating Rate Bond Etf Etf (TFLO)
Ishares Select Dividend Etf Etf (DVY)
State Street Spdr S&p 600 Small Cap Value Etf Etf (SLYV)
Spdr Gold Minishares Etf (GLDM)
Schwab Short-term U.s. Treasury Etf Etf (SCHO)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Extended Duration Treasury Index Fund Etf Shares Etf (EDV)
Microsoft Corp Equity (MSFT)
Ishares 25 Year Treasury Strips Bond Etf Etf
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Wisdomtree Floating Ratetreasury Fund Etf (USFR)
Ishares Gold Trust Micro Etf (IAUM)
Emqq The Emerging Markets Internet Etf Etf (EMQQ)
Ishares Core S&p 500 Etf Etf (IVV)
Alphabet Inc Class A Equity (GOOGL)

View all positions for Sankala Group

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
State Street Corporation
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management

View all funds holding Eledon Pharmaceuticals